Sort
8,912 grants matching “sars cov 2”
Characterization of host immune responses to SARS-CoV-2
$442,871Luigi Notarangelo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Identification of Host Directed Drug Targets for SARS-CoV-2 Using Transposon Mutagenesis
$442,750Anna Bruchez · Case Western Reserve University · R21 · FY2021 · AI
Accelerated discovery of cell-active SARS-CoV-2 polymerase inhibitors via molecular dynamic guided screening and optimization
$442,542Jennifer E. Golden · University Of Wisconsin-Madison · R21 · FY2021 · AI
Discovery of novel regulatory territories in the TNF/LT locus
$442,500Anne Goldfeld · Boston Children'S Hospital · R35 · FY2023 · GM
Discovery of novel regulatory territories in the TNF/LT locus
$442,500Anne Goldfeld · Boston Children'S Hospital · R35 · FY2022 · GM
Mechanisms of childhood obesity underlying the susceptibility to multisystem inflammatory syndrome in children (MIS-C)
$442,500Janet Chou · Boston Children'S Hospital · R01 · FY2021 · DK
Discovery of novel regulatory territories in the TNF/LT locus
$442,500Anne Goldfeld · Boston Children'S Hospital · R35 · FY2024 · GM
Discovery of novel regulatory territories in the TNF/LT locus
$442,500Anne Goldfeld · Boston Children'S Hospital · R35 · FY2025 · GM
Mechanisms of childhood obesity underlying the susceptibility to multisystem inflammatory syndrome in children (MIS-C)
$442,500Janet Chou · Boston Children'S Hospital · R01 · FY2022 · DK
Mechanisms of childhood obesity underlying the susceptibility to multisystem inflammatory syndrome in children (MIS-C)
$442,500Janet Chou · Boston Children'S Hospital · R01 · FY2023 · DK
A nanobody-based vaccine strategy to combat CoVID-19
$442,500Hidde L Ploegh · Boston Children'S Hospital · DP1 · FY2020 · AI
Digital data streams and machine learning for real-time modeling of vaccine-preventable infectious diseases
$442,337Maimuna Shahnaz Majumder · Boston Children'S Hospital · R35 · FY2025 · GM
GXI Interactions
$442,145John Blangero · University Of Texas Hlth Science Center · U19 · FY2025 · AG
In vivo functional risk assessment of patient-specific genetic variants for severe COVID-19
$442,093Kc Kent Lloyd · University Of California At Davis · U42 · FY2022 · OD
Porcine Respiratory Coronavirus as a SARS Model
$442,065Linda J. Saif · Ohio State University · R01 · FY2007 · AI
GS-441524 is Pharmacodynamically Equivalent to Remdesivir and Pharmacokinetically Superior Drug for the Treatment of COVID-19
$442,002Chun Li · University Of Tx Md Anderson Can Ctr · R21 · FY2021 · AI
Clinical Sample Collection COVID19 Patients to Align with NIAID National Study
$441,482Nitin S Baliga · Institute For Systems Biology · R01 · FY2020 · AI
Elucidating the transcriptional mechanisms that control the expression of the SARS-CoV-2 receptor ACE2
$441,479Jian Xu · Ut Southwestern Medical Center · R21 · FY2021 · AI
The role of TRIM2 and SIRPA in New World Arenavirus entry
$441,075Susan R Ross · University Of Illinois At Chicago · R01 · FY2022 · AI
The Impact of COVID-19 on Parent and Child Well-Being in Early Childhood
$441,018Kierra Marie Pettit Sattler · University Of North Carolina Greensboro · R01 · FY2024 · HD
Public Health Guidance, Neighborhoods, and SARS-CoV-2
$440,756Joseph J Galaskiewicz · University Of Arizona · · FY2023 · SBE
Decode the Impact of SARS-CoV-2 on Human Pancreas
$440,068Shuibing Chen · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · DK
Diversity and Determinants of the Immune-Inflammatory Response to SARS-CoV-2
$440,000Jane C. Figueiredo · Cedars-Sinai Medical Center · U54 · FY2022 · CA
Admin-Core-001
$440,000Jane C. Figueiredo · Cedars-Sinai Medical Center · U54 · FY2022 · CA
Novel small-molecule inhibitors of SARS-CoV-2 protease
$440,000Yongcheng Song · Baylor College Of Medicine · R21 · FY2021 · AI